Bullish
Wall Street Zen Upgrades Labcorp (NYSE:LH) to "Buy"
Wall Street Zen has upgraded Labcorp (NYSE:LH) from a "hold" to a "buy" rating. This upgrade follows Labcorp's strong Q1 earnings, where it surpassed ...
Bullish
Wall Street Zen has upgraded Labcorp (NYSE:LH) from a "hold" to a "buy" rating. This upgrade follows Labcorp's strong Q1 earnings, where it surpassed ...
Bullish
Vanguard Group Inc. has increased its stake in Labcorp Holdings Inc. (NYSE:LH) by 0.4% in the fourth quarter, bringing its total ownership to 9,850,63...
Labcorp Holdings (LH) is set to report its Q1 earnings this Thursday, with analysts expecting a 4.8% year-on-year revenue growth. The company missed r...
Neutral
Labcorp (LH) is set to report its Q1 earnings this Thursday before market open. The company previously missed revenue expectations but beat full-year ...
Neutral
Carmel Capital Partners LLC grew its position in Labcorp Holdings Inc. (NYSE:LH – Free Report) by 43.6% during the fourth quarter, according to the co...
Neutral
Birch Hill Investment Advisors LLC reduced its stake in Labcorp Holdings Inc. by 31.0%, selling 37,071 shares and now owning 82,505 shares valued at a...
Labcorp (LH) has partnered with Children's Hospital of Philadelphia (CHOP) to develop and expand specialized pediatric diagnostics for conditions like...
Neutral
Labcorp Holdings is expected to report its fiscal first-quarter 2026 earnings on April 30, with analysts forecasting a 6.8% increase in profit to $4.1...
Bullish
Labcorp Holdings Inc. (LH) is set to announce its fiscal first-quarter 2026 earnings before market open on Thursday, April 30. Analysts anticipate a p...